APA (7th ed.) Citation

Pavan, M., Bassani, D., Sturlese, M., & Moro, S. From the Wuhan-Hu-1 strain to the XD and XE variants: Is targeting the SARS-CoV-2 spike protein still a pharmaceutically relevant option against COVID-19? Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Pavan, Matteo, Davide Bassani, Mattia Sturlese, and Stefano Moro. From the Wuhan-Hu-1 Strain to the XD and XE Variants: Is Targeting the SARS-CoV-2 Spike Protein Still a Pharmaceutically Relevant Option Against COVID-19? Taylor & Francis Group.

MLA (9th ed.) Citation

Pavan, Matteo, et al. From the Wuhan-Hu-1 Strain to the XD and XE Variants: Is Targeting the SARS-CoV-2 Spike Protein Still a Pharmaceutically Relevant Option Against COVID-19? Taylor & Francis Group.